Project description
New pricing and payment schemes for health innovation
The variety of innovative technologies in healthcare delivery needs several pricing and payment models adapted in their design and implementation. However, the lack of appropriate data infrastructure, legal barriers, and unwillingness to adapt current systems often impede their use. The EU-funded HI-PRIX project will map and formulate new pricing and payment schemes to use across technology classes, therapeutic areas, settings, and healthcare systems/geographies and related principles to guide successful adjustment and flexible implementation. The project will investigate the impact on competitiveness, innovation, equity, and affordability of a pipeline of contracting modalities for health innovations and address the challenges and concerns of payers, manufacturers, healthcare professionals, and patients about different pricing models.
Objective
The variety of innovative technologies with the potential to revolutionize the delivery of health care means that the policy toolbox will need several pricing and payment models, adapted in their design and implementation according to the specific situation. Although there are examples of novel pricing and payment models, the lack of appropriate data infrastructure, legal barriers and unwillingness to adapt current systems often prevent their use. Therefore, the overall objectives of the Health Innovation Next Generation Pricing Models (HI – PRIX) project are: i) to map and formulate new pricing and payment schemes that can be used across technology classes, therapeutic areas, setting and healthcare systems/geographies together with a related set of principles that may guide successful adjustment and flexible implementation to the context of use; ii) to investigate the impact on competitiveness, innovation, equity and affordability of a pipeline of contracting modalities for health innovations; iii) to address the challenges and concerns of payers, manufacturers, healthcare professionals, and patients about different models of pricing by sustaining an effective dialogue across stakeholders’ groups about the trade-offs between affordability, innovation and patient access. Coordinated by Bocconi University, the HI-PRIX Consortium involves 18 partners from 10 European countries, including academic institutions, public authorities, healthcare providers, and independent research organizations. Through theoretical models, quantitative simulation, qualitative research work and case-studies, this three-year project structured around 10 WPs, will generate new evidence on the role of public sector in R&D and indirect medical and environmental costs in pricing and reimbursement determinations, on the pricing dynamics over pharmaceutical products’ lifecycle, on the impact of policies and incentives on the competitiveness, innovativeness and equity in the healthcare system.
Keywords
Programme(s)
Funding Scheme
HORIZON-RIA - HORIZON Research and Innovation ActionsCoordinator
20136 Milano
Italy
See on map
Participants (11)
20148 Hamburg
See on map
1090 Wien
See on map
18011 Granada
See on map
1050 Bruxelles / Brussel
See on map
08036 Barcelona
See on map
Legal entity other than a subcontractor which is affiliated or legally linked to a participant. The entity carries out work under the conditions laid down in the Grant Agreement, supplies goods or provides services for the action, but did not sign the Grant Agreement. A third party abides by the rules applicable to its related participant under the Grant Agreement with regard to eligibility of costs and control of expenditure.
08036 Barcelona
See on map
3062 PA Rotterdam
See on map
1099 085 Lisboa
See on map
75014 Paris
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
01513 Vilnius
See on map
41092 Sevilla
See on map
Partners (6)
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
00187 Roma
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
1749 004 Lisboa
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
08028 Barcelona
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
SE1 2HB LONDON
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
SW7 2AZ LONDON
See on map
Partner organisations contribute to the implementation of the action, but do not sign the Grant Agreement.
WC2A 2AE London
See on map